- Login
- Register & Subscribe
- Language: EN FR DE
IPR & Legal
GSK in $3 billion settlement with the US
Thursday 3 November 2011
GlaxoSmithKline Plc said it has reached an agreement in principle with the US government to pay $3 billion to settle civil and criminal investigations relating to sales and marketing practices, including those for Avandia (rosiglitazone).
Location
United Kingdom
European court rules against stem cell patents in research
Tuesday 18 October 2011
In a decision that will have far-reaching consequences for regenerative medicine, the European Court of Justice has ruled that inventions requiring the destruction of human embryos, or their prior use as base material, cannot be patented under European law if the purpose is purely for scientific research.
Location
Luxembourg
ECJ to rule on stem cell patents
Monday 10 October 2011
The European Court of Justice is scheduled to issue a judgment on 18 October 2011 in a case concerning the patentability of technology based on the use of human embryonic stem cells. The case involves a German researcher, Oliver Brüstle.
Location
Luxembourg
Actelion to make a $577 million provision against Asahi suit
Wednesday 29 June 2011
Actelion Ltd, the Swiss specialist in treatments for pulmonary arterial hypertension (PAH), said it is making a provision of $577 million (CHF 485 million) for damages awarded by a jury in California.
Location
Switzerland
Bavarian Nordic wins arbitration case against German research institution
Wednesday 20 April 2011
Bavarian Nordic A/S announced that it has prevailed in a two-year-old arbitration case involving a German research institution regarding rights to the technology underpinning its vaccine portfolio.
Location
Denmark
Conference Report: How Europe can do better in life science
Wednesday 6 April 2011
It is something of a truism to say that money follows success. It is less easy to say why some companies are more successful than others, and how their successes can be repeated.
Location
Belgium
ECJ strikes down proposed patent court
Tuesday 8 March 2011
The European Court of Justice (ECJ) has struck down a proposal from member states of the European Union to create a new, unified jurisdiction for the litigation of patent disputes saying the proposal is incompatible with the EU treaties.
Location
Belgium
Symphogen receives US patent on cancer compound
Monday 7 March 2011
The US Patent and Trademark Office has awarded a patent to the privately-owned Symphogen A/S of Denmark for an oncology compound that is based on a mixture of two anti-epidermal growth factor receptor (EGFR) monoclonal antibodies.
Location
Denmark
GSK raises investment in UK in response to tax measures
Tuesday 30 November 2010
GlaxoSmithKline Plc has responded speedily to a new series of tax proposals from the UK government with a commitment to invest more than £500 million in manufacturing infrastructure in the country and to raise venture capital outlays.
Location
United Kingdom
Novel technology transfer deal reported for antibody candidates
Sunday 17 January 2010
A novel licensing deal among two German universities and the UK Medical Research Council’s commercialization arm is expected to lead to the development of a potential new therapy for rheumatoid arthritis and multiple sclerosis.
Location
Germany
Select a News Category
Recent Appointments
Carolyn Compton named CEO of Critical Path Institute
Friday February 3 2012
John Perkins appointed UK chief scientific advisor
Monday January 23 2012
Briggs Morrison to lead global medicines development at AstraZeneca
Wednesday January 11 2012
Russell Greig appointed chair of AM-Pharma supervisory board
Wednesday January 4 2012
Mark Bodmer to head immunology at UCB
Tuesday January 3 2012